07.15.16
Ei, A Pharmaceutical Solutionworks will begin moving a 24-person R&D team to the Kannapolis, NC Research Campus, a 10,000-sq.-ft. lab with office space.
Ei’s R&D team is currently housed at the company’s nearby 140,000-sq.-ft. semi-solids manufacturing facility. The move expands its scientific foundation for dermatological product development and adds a significant skin biology research capability. The NCRC also offers scientific expertise on the health benefits of antioxidants and other bioactive compounds found in fruits and vegetables, which are regularly incorporated into skin care products.
Ei, a subsidiary of Product Quest Manufacturing, specializes in the development and manufacture of therapeutic, OTC, and prescription skin care products for pharma and consumer goods companies. Ei also partners with customers to develop ANDAs for generic drugs.
Ei’s chief scientific officer Charles W. Gray, Jr., Ph.D., said: “By offering best-in-class facilities, advanced scientific capabilities at the David H. Murdock Research Institute and significant opportunities for collaboration with other research centers on campus, the NC Research Campus will significantly accelerate our progress toward creating premier dermatology development capabilities and providing our customers with a robust turnkey service from early development through commercial manufacturing.”
Visit Ei at Table 150
Ei’s R&D team is currently housed at the company’s nearby 140,000-sq.-ft. semi-solids manufacturing facility. The move expands its scientific foundation for dermatological product development and adds a significant skin biology research capability. The NCRC also offers scientific expertise on the health benefits of antioxidants and other bioactive compounds found in fruits and vegetables, which are regularly incorporated into skin care products.
Ei, a subsidiary of Product Quest Manufacturing, specializes in the development and manufacture of therapeutic, OTC, and prescription skin care products for pharma and consumer goods companies. Ei also partners with customers to develop ANDAs for generic drugs.
Ei’s chief scientific officer Charles W. Gray, Jr., Ph.D., said: “By offering best-in-class facilities, advanced scientific capabilities at the David H. Murdock Research Institute and significant opportunities for collaboration with other research centers on campus, the NC Research Campus will significantly accelerate our progress toward creating premier dermatology development capabilities and providing our customers with a robust turnkey service from early development through commercial manufacturing.”
Visit Ei at Table 150
